💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 513 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$115.3B
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 2/6 (Toplam: 513)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| ETNB | 89bio, Inc. | $2.19B | $14.80 | 0.47% |
| SRPT | Sarepta Therapeutics, Inc. | $2.16B | $22.11 | 4.41% |
| OCUL | Ocular Therapeutix, Inc. | $2.05B | $11.78 | 1.34% |
| DYN | Dyne Therapeutics, Inc. | $2.00B | $14.05 | 4.29% |
| LQDA | Liquidia Corporation | $2.00B | $23.19 | 4.37% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.95B | $89.79 | 1.09% |
| VERA | Vera Therapeutics, Inc. | $1.92B | $30.09 | 1.44% |
| CERT | Certara, Inc. | $1.90B | $11.86 | 8.35% |
| QDEL | QuidelOrtho Corporation | $1.79B | $26.37 | 6.02% |
| CLDX | Celldex Therapeutics, Inc. | $1.78B | $26.77 | 2.80% |
| GPCR | Structure Therapeutics Inc. | $1.73B | $30.07 | 1.57% |
| VRDN | Viridian Therapeutics, Inc. | $1.71B | $20.99 | 3.76% |
| BHVN | Biohaven Ltd. | $1.67B | $15.80 | 8.30% |
| STOK | Stoke Therapeutics, Inc. | $1.65B | $30.19 | 0.97% |
| VCEL | Vericel Corporation | $1.61B | $31.85 | 2.81% |
| JANX | Janux Therapeutics, Inc. | $1.59B | $26.51 | 2.55% |
| RCUS | Arcus Biosciences, Inc. | $1.55B | $14.60 | 3.69% |
| HRMY | Harmony Biosciences Holdings, Inc. | $1.53B | $26.54 | 0.90% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $1.52B | $7.22 | 0.41% |
| MNKD | MannKind Corporation | $1.50B | $4.88 | 5.06% |
| GDRX | GoodRx Holdings, Inc. | $1.48B | $4.27 | 7.97% |
| PAHC | Phibro Animal Health Corporation | $1.48B | $36.39 | 2.10% |
| SDGR | Schrödinger, Inc. | $1.40B | $19.08 | 7.60% |
| HROW | Harrow Health, Inc. | $1.39B | $37.48 | 7.62% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.38B | $16.06 | 0.86% |
| OMCL | Omnicell, Inc. | $1.37B | $29.72 | 4.50% |
| NVAX | Novavax, Inc. | $1.35B | $8.33 | 3.03% |
| USPH | U.S. Physical Therapy, Inc. | $1.33B | $87.72 | 1.28% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.33B | $13.68 | 2.84% |
| SION | Sionna Therapeutics, Inc. | $1.30B | $29.42 | 3.77% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.29B | $7.99 | 2.44% |
| BLFS | BioLife Solutions, Inc. | $1.28B | $26.80 | 2.37% |
| NUVB | Nuvation Bio Inc. | $1.28B | $3.74 | 0.27% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $1.27B | $14.26 | 1.45% |
| ELVN | Enliven Therapeutics, Inc. | $1.23B | $20.82 | 2.21% |
| TRML | Tourmaline Bio, Inc. | $1.23B | $47.87 | 0.04% |
| TRVI | Trevi Therapeutics, Inc. | $1.22B | $9.99 | 0.71% |
| IMNM | Immunome, Inc. | $1.21B | $13.92 | 2.59% |
| MAZE | Maze Therapeutics, Inc. | $1.20B | $27.43 | 4.62% |
| OPK | OPKO Health, Inc. | $1.20B | $1.51 | 3.21% |
| ARDX | Ardelyx, Inc. | $1.19B | $4.94 | 2.37% |
| DVAX | Dynavax Technologies Corporation | $1.17B | $9.96 | 3.77% |
| TSHA | Taysha Gene Therapies, Inc. | $1.16B | $4.88 | 2.40% |
| SYRE | Spyre Therapeutics, Inc. | $1.16B | $19.14 | 9.59% |
| PRAX | Praxis Precision Medicines, Inc. | $1.12B | $53.26 | 2.74% |
| RLAY | Relay Therapeutics, Inc. | $1.12B | $6.50 | 4.13% |
| ZBIO | Zenas BioPharma, Inc. | $1.12B | $26.59 | 4.21% |
| LENZ | LENZ Therapeutics, Inc. | $1.11B | $38.79 | 16.13% |
| SPRY | ARS Pharmaceuticals, Inc. | $1.11B | $11.32 | 2.25% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.10B | $23.63 | 5.37% |
| INVA | Innoviva, Inc. | $1.09B | $17.35 | 0.57% |
| ATNF | 180 Life Sciences Corp. | $1.08B | $7.04 | 7.49% |
| UPB | Upstream Bio, Inc. | $1.06B | $19.62 | 0.86% |
| NKTR | Nektar Therapeutics | $1.03B | $54.34 | 2.34% |
| SEPN | Septerna, Inc. | $1.03B | $23.07 | 0.30% |
| SANA | Sana Biotechnology, Inc. | $1.03B | $4.32 | 2.92% |
| GLYC | GlycoMimetics, Inc. | $1.01B | $15.71 | 2.76% |
| PRME | Prime Medicine, Inc. | $1.01B | $5.68 | 8.83% |
| COLL | Collegium Pharmaceutical, Inc. | $1.01B | $32.04 | 3.52% |
| PCRX | Pacira BioSciences, Inc. | $1.00B | $22.35 | 3.08% |
| VERV | Verve Therapeutics, Inc. | $994.04M | $11.13 | 0.27% |
| BCAX | Bicara Therapeutics Inc. Common Stock | $970.11M | $17.78 | 2.63% |
| MDXG | MiMedx Group, Inc. | $969.13M | $6.55 | 5.35% |
| EYPT | EyePoint Pharmaceuticals, Inc. | $935.35M | $13.57 | 2.90% |
| XNCR | Xencor, Inc. | $929.34M | $13.03 | 0.23% |
| PGEN | Precigen, Inc. | $927.51M | $3.12 | 2.19% |
| PROK | ProKidney Corp. | $902.97M | $3.02 | 8.48% |
| MNMD | Mind Medicine (MindMed) Inc. | $898.60M | $11.81 | 5.52% |
| FTRE | Fortrea Holdings Inc. | $878.49M | $9.68 | 10.00% |
| ANAB | AnaptysBio, Inc. | $878.23M | $31.37 | 1.26% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $866.88M | $3.19 | 3.33% |
| KURA | Kura Oncology, Inc. | $854.95M | $9.85 | 3.90% |
| AVBP | ArriVent BioPharma, Inc. Common Stock | $846.27M | $20.86 | 1.28% |
| PHAT | Phathom Pharmaceuticals, Inc. | $838.55M | $11.82 | 1.55% |
| GERN | Geron Corporation | $835.80M | $1.31 | 5.76% |
| VIR | Vir Biotechnology, Inc. | $805.72M | $5.80 | 3.97% |
| CRMD | CorMedix Inc. | $800.91M | $10.73 | 2.45% |
| AVXL | Anavex Life Sciences Corp. | $796.24M | $9.27 | 2.63% |
| TNGX | Tango Therapeutics, Inc. | $794.40M | $7.14 | 2.46% |
| ABUS | Arbutus Biopharma Corporation | $787.88M | $4.11 | 3.75% |
| EMBC | Embecta Corp. | $782.53M | $13.38 | 1.55% |
| URGN | UroGen Pharma Ltd. | $771.69M | $16.68 | 1.58% |
| IOVA | Iovance Biotherapeutics, Inc. | $759.89M | $2.10 | 4.11% |
| RZLT | Rezolute, Inc. | $751.01M | $8.27 | 6.34% |
| NRIX | Nurix Therapeutics, Inc. | $750.34M | $9.76 | 10.13% |
| DAWN | Day One Biopharmaceuticals, Inc. | $741.61M | $7.24 | 2.69% |
| AKBA | Akebia Therapeutics, Inc. | $729.15M | $2.75 | 4.84% |
| OLMA | Olema Pharmaceuticals, Inc. | $725.46M | $10.57 | 1.03% |
| GYRE | Gyre Therapeutics, Inc. | $722.45M | $7.96 | 11.33% |
| TYRA | Tyra Biosciences, Inc. | $720.56M | $13.52 | 2.17% |
| IKNA | Ikena Oncology, Inc. | $718.82M | $17.16 | 1152.55% |
| TERN | Terns Pharmaceuticals, Inc. | $713.22M | $8.15 | 4.12% |
| ARVN | Arvinas, Inc. | $694.53M | $9.46 | 1.36% |
| ERAS | Erasca, Inc. | $683.65M | $2.41 | 1.63% |
| AQST | Aquestive Therapeutics, Inc. | $652.23M | $6.54 | 2.24% |
| KROS | Keros Therapeutics, Inc. | $637.66M | $15.70 | 2.61% |
| MGTX | MeiraGTx Holdings plc | $630.45M | $7.84 | 10.50% |
| KOD | Kodiak Sciences Inc. | $625.73M | $11.87 | 12.40% |
| GLUE | Monte Rosa Therapeutics, Inc. | $620.06M | $10.04 | 18.68% |
| ZVRA | Zevra Therapeutics, Inc. | $618.05M | $11.01 | 1.76% |